• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 444-458 of 964 results

2138 Exhibit: Ex 2138 FDA EvzioR 2 mg Orange Book

Document IPR2019-00685, No. 2138-174 Exhibit - Ex 2138 FDA EvzioR 2 mg Orange Book (P.T.A.B. Dec. 20, 2019)

cite Cite Document

1011 Exhibit: Nalox1011 Grassin Delyle 2012

Document IPR2019-00685, No. 1011-11 Exhibit - Nalox1011 Grassin Delyle 2012 (P.T.A.B. Feb. 19, 2019)

cite Cite Document

1242 Exhibit: Nalox1242 Zuckerman 2014

Document IPR2019-00685, No. 1242-294 Exhibit - Nalox1242 Zuckerman 2014 (P.T.A.B. Mar. 12, 2020)

cite Cite Document

2179 Exhibit: Ex 2179 Weber 2012

Document IPR2019-00685, No. 2179-211 Exhibit - Ex 2179 Weber 2012 (P.T.A.B. Dec. 20, 2019)

cite Cite Document

1058 Exhibit: Nalox1058 US Provisional Patent App 61 953379

Document IPR2019-00685, No. 1058-57 Exhibit - Nalox1058 US Provisional Patent App 61 953379 (P.T.A.B. Feb. 19, 2019)

cite Cite Document

1047 Exhibit: Nalox1047 Robertson 2009

Document IPR2019-00685, No. 1047-45 Exhibit - Nalox1047 Robertson 2009 (P.T.A.B. Feb. 19, 2019)

cite Cite Document

2317 Exhibit: Ex 2317 Parikh 2011

Document IPR2019-00685, No. 2317-332 Exhibit - Ex 2317 Parikh 2011 (P.T.A.B. Apr. 24, 2020)

cite Cite Document

2136 Exhibit: Ex 2136 FDA NarcanR Nasal Spray Approved

Document IPR2019-00685, No. 2136-172 Exhibit - Ex 2136 FDA NarcanR Nasal Spray Approved (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2122 Exhibit: Ex 2122 Narcan Nasal Spray Label

Document IPR2019-00685, No. 2122-158 Exhibit - Ex 2122 Narcan Nasal Spray Label (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2026 Exhibit: Opiant2026 Teva Case Schedule Stipulation

Document IPR2019-00685, No. 2026-92 Exhibit - Opiant2026 Teva Case Schedule Stipulation (P.T.A.B. May. 28, 2019)

cite Cite Document

1001 Exhibit: Nalox1001 U S Patent 9,211,253

Document IPR2019-00685, No. 1001 Exhibit - Nalox1001 U S Patent 9,211,253 (P.T.A.B. Feb. 19, 2019)

cite Cite Document

1062 Exhibit: Nalox1062 McDermott

Document IPR2019-00685, No. 1062-61 Exhibit - Nalox1062 McDermott (P.T.A.B. Feb. 19, 2019)

cite Cite Document

1219 Exhibit: Nalox1219 FDA B Names

Document IPR2019-00685, No. 1219-272 Exhibit - Nalox1219 FDA B Names (P.T.A.B. Mar. 12, 2020)

cite Cite Document

1202 Exhibit: SUPPLEMENTAL DECLARATION OF GUNTHER HOCHHAUS, PhD

Document IPR2019-00685, No. 1202-304 Exhibit - SUPPLEMENTAL DECLARATION OF GUNTHER HOCHHAUS, PhD (P.T.A.B. Mar. 12, 2020)

cite Cite Document

1224 Exhibit: Nalox1224 Kim 1997

Document IPR2019-00685, No. 1224-277 Exhibit - Nalox1224 Kim 1997 (P.T.A.B. Mar. 12, 2020)

cite Cite Document
<< 1 2 3 4 5 ... 30 31 32 33 34 ... >>